CME/CE: Beta-Blocker After PCI Might Cut Infarct Damage
By: Alere Staff
February 2, 2016 – February 2, 2018
Physicians: 0.25 AMA PRA Category 1 Credit(s) ™
According to the proof-of-concept BEAT-AMI trial, intravenous use of the beta-blocker esmolol (Brevibloc) may reduce myocardial injury in ST-elevation myocardial infarction (STEMI).